MINERVA NEUROSCIENCES, INC.

Analyst Reco. Minerva Neurosciences, Inc.

Equities

NERV

US6033802058

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-03 EDT			5-day change	1st Jan Change
2.37 ^USD	+0.85%		-2.73%	-61.46%

05-01	Minerva Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-27	Sector Update: Health Care Stocks Ease Late Afternoon	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Price Target on Minerva Neurosciences to $11 From $8, Maintains Neutral Rating	23-08-02	MT
HC Wainwright Downgrades Minerva Neurosciences to Neutral From Buy	22-11-10	MT
JMP Securities Downgrades Minerva Neurosciences to Market Perform From Outperform, Removes $21 Price Target	22-10-17	MT
HC Wainwright Adjusts Price Target on Minerva Neurosciences to $24 From $40, Reiterates Buy Rating	22-08-23	MT
HC Wainwright Adjusts Minerva Neurosciences' Price Target to $5 from $10, Keeps Buy Rating	22-03-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer